NRX Pharmaceuticals, Inc.

NRX Pharmaceuticals, Inc., trading under ticker BRPA and associated with the blank-check vehicle Big Rock Partners Acquisition Corp., filed an 8-K with the SEC on March 21, 2024, under accession number 0001104659-24-037389. Big Rock Partners served as the SPAC's sponsor, and the vehicle completed its IPO in 2018 targeting the healthcare and biopharmaceutical sector. The company subsequently completed its de-SPAC business combination with NRX Pharmaceuticals, a clinical-stage biopharmaceutical company focused on treatments for life-threatening conditions. The March 2024 filing reflects the post-merger public entity's ongoing reporting obligations. For full filing history, deal terms, and sponsor details on BRPA and thousands of other SPACs, sign up for complete data access at SpacDesk.